Literature DB >> 17260927

Model-based estimation of the attributable risk in case-control and cohort studies.

Christopher Cox1.   

Abstract

In a comprehensive review, Benichou recently discussed adjusted estimators of the attributable risk (AR). Among these are model-based estimates, where adjustment for confounding factors is based on a regression model. Different model-based approaches have been developed for case-control and cohort studies. The purpose of this article is to provide a detailed review and illustration of model-based methods for both types of sampling. For case-control studies, we show that two previously proposed approaches for the common case of a logistic regression model are in fact identical. This allows a unified approach to the estimation of the adjusted AR, which also accommodates stratified sampling. For cohort studies, a loglinear model is proposed for the case where cross-sectional sampling allows estimation of the prevalence of exposure; the approach can also be used for stratified sampling when the prevalence is known or can be estimated. For both designs, the standard error of the adjusted AR is estimated using the delta method. Estimation of the generalized AR is also discussed for both types of sampling. Examples show that for even fairly complex models, the computations are practical using standard statistical software. The bootstrap provides an easily implemented alternative to the delta method for the computation of standard errors.

Mesh:

Year:  2006        PMID: 17260927     DOI: 10.1177/0962280206071930

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  8 in total

1.  Attributable risk in men in two French case-control studies on mesothelioma and asbestos.

Authors:  Aude Lacourt; Patrick Rolland; Céline Gramond; Philippe Astoul; Soizick Chamming's; Stéphane Ducamp; Catherine Frenay; Françoise Galateau-Sallé; Anabelle Gilg Soit Ilg; Ellen Imbernon; Nolwenn Le Stang; Jean Claude Pairon; Marcel Goldberg; Yuriko Iwatsubo; Louis-Rachid Salmi; Patrick Brochard
Journal:  Eur J Epidemiol       Date:  2010-09-07       Impact factor: 8.082

2.  Proportion of Orofacial Clefts Attributable to Recognized Risk Factors.

Authors:  Janhavi R Raut; Regina M Simeone; Sarah C Tinker; Mark A Canfield; R Sue Day; A J Agopian
Journal:  Cleft Palate Craniofac J       Date:  2018-05-04

3.  Concocting that Magic Elixir: Successful Grant Application Writing in Dissemination and Implementation Research.

Authors:  Ross C Brownson; Graham A Colditz; Maureen Dobbins; Karen M Emmons; Jon F Kerner; Margaret Padek; Enola K Proctor; Kurt C Stange
Journal:  Clin Transl Sci       Date:  2015-11-18       Impact factor: 4.689

4.  Survival attributable to an exposure.

Authors:  Christopher Cox; Haitao Chu; Alvaro Muñoz
Journal:  Stat Med       Date:  2009-11-20       Impact factor: 2.373

5.  Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS.

Authors:  David G Ostrow; Michael W Plankey; Christopher Cox; Xiuhong Li; Steven Shoptaw; Lisa P Jacobson; Ronald C Stall
Journal:  J Acquir Immune Defic Syndr       Date:  2009-07-01       Impact factor: 3.731

6.  Model-Based Estimation of the Attributable Risk: A Loglinear Approach.

Authors:  Christopher Cox; Xiuhong Li
Journal:  Comput Stat Data Anal       Date:  2012-05-07       Impact factor: 1.681

7.  Obesity, mammography use and accuracy, and advanced breast cancer risk.

Authors:  Karla Kerlikowske; Rod Walker; Diana L Miglioretti; Arati Desai; Rachel Ballard-Barbash; Diana S M Buist
Journal:  J Natl Cancer Inst       Date:  2008-11-25       Impact factor: 13.506

8.  The Population Impact of Late Presentation With Advanced HIV Disease and Delayed Antiretroviral Therapy in Adults Receiving HIV Care in Latin America.

Authors:  Pablo F Belaunzarán-Zamudio; Yanink N Caro-Vega; Bryan E Shepherd; Peter F Rebeiro; Brenda E Crabtree-Ramírez; Claudia P Cortes; Beatriz Grinsztejn; Eduardo Gotuzzo; Fernando Mejia; Denis Padgett; Jean W Pape; Vanessa Rouzier; Valdilea Veloso; Sandra Wagner Cardoso; Catherine C McGowan; Juan G Sierra-Madero
Journal:  Am J Epidemiol       Date:  2020-06-01       Impact factor: 4.897

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.